Analyst Reco. Hikma Pharmaceuticals PLC

Equities

Market Closed - London S.E. Other stock markets 11:35:15 2024-05-02 am EDT			5-day change	1st Jan Change
1,925 ^GBX	-0.52%		+5.83%	+7.60%

Apr. 26	HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets
Apr. 25	Hikma Pharmaceuticals backs outlook after making strong start to 2024	AN

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets	Apr. 26
RBC Keeps Hikma Pharmaceuticals at Sector Perform, Raises PT	Feb. 29	MT
Barclays cuts Direct Line to equal weight	Feb. 29	AN
Barclays raises Breedon but cuts Domino's Pizza	Feb. 23	AN
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	Feb. 22
JPMorgan Keeps Hikma Pharmaceuticals at Overweight, Raises PT	Feb. 22	MT
Berenberg raises Moneysupermarket.com to 'buy'	Feb. 22	AN
RBC Raises Hikma Pharmaceuticals PT, Affirms Sector Perform Rating	Jan. 09	MT
Berenberg cuts target prices for miners	Jan. 09	AN
HIKMA PHARMACEUTICALS : Incorporating a healthy ongoing recovery	Jan. 08
Jefferies Reduces Hikma Pharmaceuticals PT, Keeps at Hold	Dec. 20	MT
UBS cuts DS Smith; Kepler likes Genus	Dec. 20	AN
Barclays Keeps Hikma Pharmaceuticals at Equalweight, Lowers PT	Dec. 19	MT
Peel Hunt raises Flutter to 'buy' from 'hold'	Dec. 19	AN
JPMorgan Trims Hikma Pharmaceuticals PT, Keeps Overweight Rating	Dec. 05	MT
Goldman lifts Landsec and British Land	Dec. 05	AN
Jefferies Downgrades Hikma Pharmaceuticals to Hold from Buy, Trims PT	Nov. 07	MT
Hikma's Generics Recovery Remains Uncertain Despite Upgraded Outlook, Berenberg Says	Nov. 07	MT
Watches of Switzerland impresses HSBC; Asos cut	Nov. 07	AN
HIKMA PHARMACEUTICALS : Healthy Q3; Injectables’ temporary constraints shouldn’t be a worry	Nov. 03

No results for this search

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 06:50 am EDT